Tonix publishes Journal of Virology study showing 2022 mpox clade IIb up to 100,000-fold less virulent than 2003 clade IIa
TNXP•Research adds murine models to support countermeasure evaluation
Research identified three new murine models to study mpox infection, supporting evaluation of medical countermeasures.
The work aligns with development of TNX-801, a live, attenuated horsepox-based vaccine candidate aimed at preventing mpox and smallpox.
Journal of Virology study highlights lower virulence in 2022 mpox strain
Tonix reported Journal of Virology data showing the 2022 mpox outbreak strain (clade IIb) was up to 100,000-fold less virulent than clade IIa.
